by Clinical Neuropsychologist Online | Friday, November 13, 2026 | Dementia
ABSTRACT INTRODUCTION Plasma brain-derived phosphorylated Tau217 (BD-pTau217) may provide a more Alzheimer’s disease (AD) -specific plasma tau measure than total pTau217, but its prognostic value is unclear. METHODS We compared baseline plasma NULISAseq...
by Clinical Neuropsychologist Online | Friday, November 13, 2026 | Dementia
Abstract INTRODUCTION It is unknown how soluble tau protein turns into insoluble tau tangle. We tested whether tau ubiquitination and phosphorylation were associated with tau tangles. METHODS Data were from participants in the Rush Memory and Aging Project. Proteomic...
by Clinical Neuropsychologist Online | Wednesday, November 11, 2026 | Dementia
Abstract BACKGROUND CD8+ T-cell–mediated neuroimmune activation increases with aging and contributes to Alzheimer’s disease (AD), yet the molecular cues that drive their recruitment into the brain remain largely undefined. METHODS We quantified Cathepsin E...
by Clinical Neuropsychologist Online | Wednesday, November 11, 2026 | Dementia
Abstract INTRODUCTION Diabetes mellitus (DM) is a major risk factor for dementia, yet it remains unclear whether DM accelerates cognitive decline through amyloid beta (Aβ) or tau accumulation in Alzheimer’s disease (AD). METHODS In this study, we included 2784...
by Clinical Neuropsychologist Online | Wednesday, November 11, 2026 | Dementia
Abstract Alzheimer’s disease and related dementias (ADRD) pose a global public health challenge, and epidemiological evidence underscores profound disparities in ADRD risk and outcomes that are rooted in social/structural determinants of health (S/SDOH). Yet,...